These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 912156)

  • 1. Screening for adverse drug reactions.
    Bulpitt CJ
    Br J Hosp Med; 1977 Oct; 18(4):329, 333-4. PubMed ID: 912156
    [No Abstract]   [Full Text] [Related]  

  • 2. [From suspected adverse reactions to verified adverse reactions - contribution of epidemiology].
    Greiser E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1540-50. PubMed ID: 417498
    [No Abstract]   [Full Text] [Related]  

  • 3. Unreported adverse drug reactions determined by screening physician orders for diphenhydramine.
    Fraterrigo CC; Estep JM; Palmer MA
    Hosp Pharm; 1981 Aug; 16(8):421-3, 426. PubMed ID: 10252375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic monitoring of adverse reactions.
    Shapiro S
    Int J Clin Pharmacol; 1973 Apr; 7(2):178-9. PubMed ID: 4731284
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors for adverse drug reactions--epidemiological approaches.
    Agents Actions Suppl; 1990; 29():1-149. PubMed ID: 2316428
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adverse reactions to drugs as ambulatory emergencies at the University Clinical Hospital in Valladolid].
    Med Clin (Barc); 1987 Jun; 89(3):130-1. PubMed ID: 3626654
    [No Abstract]   [Full Text] [Related]  

  • 7. Interpretation of studies on adverse drug reactions.
    Miller RR
    Am J Hosp Pharm; 1977 Jul; 34(7):753-4. PubMed ID: 888839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients.
    McKenzie MW; Stewart RB; Weiss CF; Cluff LE
    Am J Hosp Pharm; 1973 Oct; 30(10):898-903. PubMed ID: 4747029
    [No Abstract]   [Full Text] [Related]  

  • 9. Updating of a method for causality assessment of adverse drug reactions.
    Venulet J; Ciucci AG; Berneker GC
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):559-68. PubMed ID: 3781677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving how we evaluate the toxicity of approved drugs.
    Reidenberg MM
    Clin Pharmacol Ther; 2006 Jul; 80(1):1-6. PubMed ID: 16815311
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of reporting systems of adverse reactions to drugs and care.
    Jorup-Rönström C; Britton S
    Scand J Soc Med; 1983; 11(3):87-9. PubMed ID: 6669976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacist and adverse drug reaction reporting.
    Pearson K
    Hosp Pharm; 1982 Aug; 17(8):421-2, 427-30. PubMed ID: 10256700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the register of adverse drug reactions.
    Drug Ther Bull; 1977 Sep; 15(18):69. PubMed ID: 891365
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse drug reactions in a developing country: problems encountered in a surveillance programme in a Nigerian hospital.
    Okonkwo PO; Egere JU; Ogbuokiri JE
    Cent Afr J Med; 1980 Nov; 26(11):239-42. PubMed ID: 7471190
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the registration of congenital abnormalities in Belgian civilian vital statistics].
    De Wals P; Vincotte-Mols M; Lys F; Borlee I; Lechat MF
    Arch Belg; 1987; 45(11-12):441-51. PubMed ID: 3504139
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse Drug Reactions Advisory Committee: ADRAC. Report for 1977.
    Med J Aust; 1978 Nov; 2(11):suppl 1-2. PubMed ID: 32466
    [No Abstract]   [Full Text] [Related]  

  • 17. The economics of adverse reactions to drugs.
    Mach EP; Venulet J
    WHO Chron; 1975 Mar; 29(3):79-84. PubMed ID: 1121866
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reports to the Committee of Adverse Drug Reactions].
    Juul P
    Ugeskr Laeger; 1986 May; 148(22):1354-5. PubMed ID: 3727133
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug-induced blood dyscrasias. Reports to the Committee on Adverse Drug Reactions 1968-1983].
    Jennum P; Kristensen MB
    Ugeskr Laeger; 1985 Aug; 147(32):2539-41. PubMed ID: 4060328
    [No Abstract]   [Full Text] [Related]  

  • 20. The epidemiology of adverse drug reactions. A review and perspective.
    Gardner P; Cluff LE
    Johns Hopkins Med J; 1970 Feb; 126(2):77-87. PubMed ID: 4909109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.